Immunotoxicity evaluation by immune function tests: Focus on the T-dependent antibody response (TDAR) [Overview of a workshop session at the 45th Annual Meeting of the Society of Toxicology (SOT) March 5-9, 2006 San Diego, CA]

Journal of Immunotoxicology

Volumn 4, Issue 2, 2007, Pages 143-147

  Herzyk, Danuta J ^a   Holsapple, Michael ^b  

^a GLAXOSMITHKLINE   (United States)

^b ILSI HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE   (United States)

Author keywords

Hazard identification; Immune function tests; Immunotoxicity; Risk assessment; T cell dependent antibody response (TDAR)

Indexed keywords

KEYHOLE LIMPET HEMOCYANIN;

ANTIBODY RESPONSE; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE SYSTEM; IMMUNOASSAY; IMMUNOTOXICITY; PLAQUE FORMING CELL; PRIORITY JOURNAL; RISK ASSESSMENT; SHEEP ERYTHROCYTE; T CELL DEPENDENT ANTIBODY RESPONSE TEST; TOXICITY TESTING;

ANIMALIA; OVIS ARIES;

EID: 34250210721     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.1080/15476910701337308     Document Type: Conference Paper

References (11)

1. CPMP. Committee on Proprietary Medicinal Products. Note for Guidance on Repeated-Dose Toxicity 2000, CPMP/SWP/1042/99 〈http://www.emea.eu. int.〉
2. EPA. United States Environmental Protection Agency. Health Effects Test Guidelines: Immunotoxicity. 1998, OPPTS 870.7800. 〈http://www.epa. gov/opptsfrs/publications.〉
3. FDA. United States Food and Drug Administration. 2002. Guidance for Industry: Immunotoxicology Evaluation of Investigational New Drugs 〈http://www.fda.gov/cder/guidance〉.
4. Gore, E. R., Gower, J., Kurali, E., Sui, J. L., Bynum, J., Ennulat, D., and Herzyk, D. 2004. Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation. Toxicology 197:23-35.
5. Herzyk, D. J., and Gore, E. R. 2004. Adequate immunotoxicity testing in drug development. Toxicol. Lett. 149:115-122.
6. ICH. 2006. International Conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH Harmonised Tripartite Guideline Immunotoxicity Studies For Human Pharmaceuticals S8.
7. Ladics, G. S., Smith, C., Elliott, G. S., Slone, T. W., and Loveless S. E. 1998. Further evaluation of the incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats in a standard toxicology study. Toxicology 126:137-152.
8. Luster, M. I., Munson, A. E., Thomas, P. T., Holsapple, M. P., Fenters, J. D., White, K. L., Jr., Lauer, L. D., Germolec, D. R., Rosenthal, G. J., and Dean, J. H. 1988. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 10:2-19.
9. Luster, M. I., Portier, C., Pait, D. G., Rosenthal, G. J., Germolec, D. R., Corsini, E., Blaylock, B. L., Pollock, P., Kouchi, Y., Craig, W., White, K. L., Jr., Munson, A. E., and Comment, C. E. 1993. Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam. Appl. Toxicol. 21:71-82.
10. Luster, M. I., Portier, C., Pait, D. G., White, K. L., Jr., Gennings, C., Munson, A. E., and Rosenthal, G. J. 1992. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18:200-210.
11. Temple, L., Kawabata, T. T., Munson, A. E., and White, K. L. Jr. 1993. Comparison of ELISA and plaque-forming cell assay for measuring the humoral immune response to SRBC in animals treated with benzo(a)pyrene or cyclophosphamide. Fundam. Appl. Toxicol. 21:412-419.